LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

The new Cochlear™ Nucleus® Nexa® System is the first and only hearing implant featuring internal memory and upgradeable firmware. Approximately 63 million people in India suffer from significant ...

LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...

Hearing is one of those things most people never think about until it’s gone. For millions living with severe to profound hearing loss, a cochlear implant isn’t just a device. It’s a way back to ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cochlear ( (AU:COH)) just unveiled an ...

Cochlear's interim 2026 underlying net profit after tax was down 10%. Sales fell 2% due to contracting delays for the new Nucleus Nexa implant in developed markets. Inefficient manufacturing and ...

The Cochlear Ltd (ASX: COH) share price is in focus today after the hearing implant leader posted a modest 1% lift in sales revenue to $1,176 million for the half year ended December 2025, but ...

Mumbai (Maharashtra) [India], March 2: Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear Nucleus Nexa System - the world's first and only smart cochlear implant ...